Drug Delivery News and Research

RSS

Drug delivery is a term that refers to the delivery of a pharmaceutical compound into the body. Most common methods of delivery include the preferred non-invasive oral (through the mouth), nasal, pneumonial (inhalation), and rectal routes. Much research is now focussing on nanotechnology as a drug delivery method.

Ultrasound technology to treat cancer

Ultrasound scans might be most familiar for getting a peek at a developing fetus, but the technology could also be used to treat cancer. A partnership between UC Davis, Siemens Medical Systems and ImaRx Inc., funded by a National Cancer Institute grant, will study ways to deliver drugs to tumors using focused ultrasound.

17 Jun 2004

Research on the potential oral delivery of a current intravenous cancer drug using polymeric nano-delivery systems technology

Labopharm Inc. today announced that it has entered into an agreement with Debiopharm S.A. under which Debiopharm has engaged Labopharm to conduct research on the potential oral delivery of a current intravenous cancer drug using Labopharm’s proprietary polymeric nano-delivery systems technology (also referred to as micelles technology).

16 Jun 2004

Better understanding of Tamoxifen and how breast cancer patients develop resistance

A new study by researchers at Georgetown’s Lombardi Comprehensive Cancer Center may have implications for the thousands of breast cancer patients who develop resistance to antiestrogen drugs such as Tamoxifen®. The work is published in the June 1 issue of Cancer Research.

11 Jun 2004

Researchers win Kaye prize for gastro-retentive sustained release drug delivery system

Despite advances made in "sustained delivery" drug delivery technologies in recent years, a problem still persists in trying to obtain controlled release of a wide variety of medications that have only a "narrow absorption window" in the upper part of the intestines. That is, these drugs are absorbed rather quickly after being swallowed, negating the beneficial effects of "once-a-day" medication.

9 Jun 2004

BioSante publishes oral insulin study

BioSante Pharmaceuticals, Inc. has announced the publication of positive results of a preclinical study of its proprietary calcium phosphate nanoparticle (CAP) delivery system for the oral delivery of insulin in the June 11 issue of the peer-reviewed International Journal of Pharmaceutics.

2 Jun 2004

Novel molecular targeting technologies to deliver gene-silencing therapy

Researchers have combined novel molecular targeting technologies to deliver gene-silencing therapy specifically to tumor cells shielded by a normally impermeable obstacle, the blood brain barrier.

1 Jun 2004

New Australian asthma invention provides an incentive for children to inhale their medication correctly

Parents with asthmatic children often experience difficulty with their children resisting medication, particularly using the recommended ‘spacer’ devices which separate the drug dispensing pMDI or ‘puffer’ and the mask through which children inhale their medicine.

26 May 2004

Speakers will predict the future of where the field of cancer diagnosis and treatment is going in the next ten years

Nexxus, the West of Scotland Bioscience Network will hold the second event of the Horizons in Biomedicine Series today at 6.30pm at the Glasgow Science Centre.

25 May 2004

Bone repair using breakthrough material

A breakthrough in polymer development means that soon there may be a radical new treatment for people with broken bones - a special kind of material that can 'glue' the bone back together and support it while it heals. The polmer material is designed to break down as the bone regrows leaving only natural tissue.

20 May 2004

IMPAX receives final FDA approval for generic version of Sinemet CR

IMPAX Laboratories, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted final approval to the Company's Abbreviated New Drug Application (ANDA) for Carbidopa/Levodopa Extended Release Tablets, its generic version of Sinemet(R) CR tablets.

17 May 2004

Britannia Pharmaceuticals’ partner receives FDA approval for Parkinson’s disease treatment

Britannia Pharmaceuticals Limited announced today that U.S.-based Bertek Pharmaceuticals Inc., the branded subsidiary of Mylan Laboratories Inc has received approval from the Food and Drug Administration for APOKYN (apomorphine hydrochloride injection).

13 May 2004

Biochip technology to revolutionise the pharmaceutical industry

Advancements in biotechnology have culminated in its integration with semiconductor technologies such as micro-electromechanical systems, resulting in the evolution of biochips. Biochips provide pharma companies with sophisticated tools for speedy development of drugs and accurate diagnosis and understanding of biological mechanisms.

13 May 2004

Bentley Pharmaceuticals lists on NYSE

The Company anticipates that its common stock will begin trading on the NYSE on Wednesday, May 12, 2004, under its current ticker symbol, “BNT.” Bentley’s common stock will continue to trade on the American Stock Exchange until that date

12 May 2004

World's first gene therapy trial aimed at preventing cancer

The concept seems straightforward. If, at its heart, cancer is a disease of genes, then giving patients new genes should disarm cancer. Such treatment would replace missing or faulty genes that keep cell growth in check, or would flush the body with "super genes" that could attack and destroy cancer.

5 May 2004

Fabrication of microscopic polymeric structures on top of a human hair

Researchers in the laboratory of Boston College Chemistry Professor John T. Fourkas have demonstrated the fabrication of microscopic polymeric structures on top of a human hair.

3 May 2004

Functional genomics and proteomics may accelerate the discovery of new drugs and therapeutic molecules

Functional genomics and proteomics have been quite successful in identifying functions of potential therapeutic targets such as encoded proteins. In fact, the possibilities of identifying more than 10,000 novel target antigens in the human genome may accelerate the discovery of new drugs and therapeutic molecules.

29 Apr 2004

Drug Delivery News and Research

Further Reading

Ultrasound technology to treat cancer

Research on the potential oral delivery of a current intravenous cancer drug using polymeric nano-delivery systems technology

Better understanding of Tamoxifen and how breast cancer patients develop resistance

Researchers win Kaye prize for gastro-retentive sustained release drug delivery system

BioSante publishes oral insulin study

Novel molecular targeting technologies to deliver gene-silencing therapy

New Australian asthma invention provides an incentive for children to inhale their medication correctly

Speakers will predict the future of where the field of cancer diagnosis and treatment is going in the next ten years

Bone repair using breakthrough material

IMPAX receives final FDA approval for generic version of Sinemet CR

Britannia Pharmaceuticals’ partner receives FDA approval for Parkinson’s disease treatment

Biochip technology to revolutionise the pharmaceutical industry

Bentley Pharmaceuticals lists on NYSE

World's first gene therapy trial aimed at preventing cancer

Fabrication of microscopic polymeric structures on top of a human hair

Functional genomics and proteomics may accelerate the discovery of new drugs and therapeutic molecules

Carbohydrate-binding proteins are becoming extremely useful in curing various illnesses

First generic cultivate(R) cream to receive tentative FDA approval

Oxford researchers find possible new type of antibiotic

SkyePharma delivery technologies for respiratory drugs to feature at two international conferences

Must Know Trends for Drug Delivery Systems and the Crucial Role of Materials Testing eBook eBook

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest Life Science News